Integrated Advisors Network’s Bristol-Myers Squibb BMY Stock Holding History

Integrated Advisors Network’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.3M	Sell	21,431 -3,592	-14%	-$209K	0.07%	276
2025 Q4	$1.35M	Buy	25,023 +1,219	+5%	+$58.6K	0.06%	295
2025 Q3	$1.07M	Buy	23,804 +3,517	+17%	+$164K	0.05%	350
2025 Q2	$939K	Sell	20,287 -126	-0.6%	-$6.18K	0.04%	369
2025 Q1	$1.24M	Buy	20,413 +3,025	+17%	+$176K	0.06%	284
2024 Q4	$983K	Sell	17,388 -1,550	-8%	-$86.6K	0.05%	309
2024 Q3	$980K	Sell	18,938 -5,434	-22%	-$255K	0.05%	322
2024 Q2	$1.01M	Sell	24,372 -72,855	-75%	-$3.26M	0.05%	304
2024 Q1	$5.27M	Buy	97,227 +65,448	+206%	+$3.33M	0.27%	96
2023 Q4	$1.63M	Sell	31,779 -6,160	-16%	-$323K	0.09%	222
2023 Q3	$2.2M	Sell	37,939 -5,942	-14%	-$364K	0.13%	182
2023 Q2	$2.81M	Sell	43,881 -55,556	-56%	-$3.73M	0.16%	162
2023 Q1	$6.89M	Buy	99,437 +47,577	+92%	+$3.36M	0.41%	53
2022 Q4	$3.73M	Buy	51,860 +1,101	+2%	+$83K	0.24%	123
2022 Q3	$3.61M	Sell	50,759 -2,100	-4%	-$152K	0.25%	107
2022 Q2	$4.07M	Sell	52,859 -56,888	-52%	-$4.33M	0.26%	109
2022 Q1	$8.02M	Buy	109,747 +16,776	+18%	+$1.13M	0.47%	46
2021 Q4	$5.8M	Buy	92,971 +8,043	+9%	+$472K	0.34%	67
2021 Q3	$5.03M	Buy	84,928 +49,168	+137%	+$3.24M	0.33%	65
2021 Q2	$2.39M	Sell	35,760 -40,976	-53%	-$2.67M	0.18%	146
2021 Q1	$4.84M	Buy	76,736 +5,921	+8%	+$368K	0.44%	54
2020 Q4	$4.39M	Buy	70,815 +171	+0.2%	+$10.5K	0.48%	45
2020 Q3	$4.26M	Sell	70,644 -4,339	-6%	-$261K	0.54%	47
2020 Q2	$4.41M	Buy	74,983 +1,498	+2%	+$89.6K	0.52%	41
2020 Q1	$4.1M	Buy	73,485 +3,248	+5%	+$199K	0.8%	29
2019 Q4	$4.51M	Buy	+70,237	New	+$4.02M	0.61%	37

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Integrated Advisors Network's BMY Position: Q1 2026 in Review

Integrated Advisors Network reduced its Bristol-Myers Squibb (BMY) stake by 14% in Q1 2026, selling an estimated $209K and leaving 21,431 shares worth $1.3M. The position accounts for 0.07% of the portfolio, ranked #276.

Integrated Advisors Network first reported a position in BMY in Q4 2019 and has held it in 26 quarters since. The position peaked at $8.02M in Q1 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Integrated Advisors Network held 21,431 shares of Bristol-Myers Squibb worth $1.3M as of Q1 2026.
Integrated Advisors Network sold 3,592 Bristol-Myers Squibb shares in Q1 2026, an estimated $209K.
Bristol-Myers Squibb made up 0.07% of Integrated Advisors Network's portfolio in Q1 2026, its #276 holding.
Integrated Advisors Network first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 26 quarters since.
Integrated Advisors Network's Bristol-Myers Squibb position peaked at $8.02M in Q1 2022.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Integrated Advisors Network's 13F filing for Q1 2026, filed 28 Apr 2026.